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Intraflagellar transport (IFT) depends on two evolutionarily conserved modules, subcomplexes A (IFT-A) and B (IFT-B), to drive ciliary
assembly and maintenance. All six IFT-A components and their motor protein, DYNC2H1, have been linked to human skeletal ciliopa-
thies, including asphyxiating thoracic dystrophy (ATD; also known as Jeune syndrome), Sensenbrenner syndrome, andMainzer-Saldino
syndrome (MZSDS). Conversely, the 14 subunits in the IFT-B module, with the exception of IFT80, have unknown roles in human
disease. To identify additional IFT-B components defective in ciliopathies, we independently performed different mutation analyses:
candidate-based sequencing of all IFT-B-encoding genes in 1,467 individuals with a nephronophthisis-related ciliopathy or whole-
exome resequencing in 63 individuals with ATD. We thereby detected biallelic mutations in the IFT-B-encoding gene IFT172 in 12 fam-
ilies. All affected individuals displayed abnormalities of the thorax and/or long bones, as well as renal, hepatic, or retinal involvement,
consistent with the diagnosis of ATD or MZSDS. Additionally, cerebellar aplasia or hypoplasia characteristic of Joubert syndrome was
present in 2 out of 12 families. Fibroblasts from affected individuals showed disturbed ciliary composition, suggesting alteration of ciliary
transport and signaling. Knockdown of ift172 in zebrafish recapitulated the human phenotype and demonstrated a genetic interaction
between ift172 and ift80. In summary, we have identified defects in IFT172 as a cause of complex ATD andMZSDS. Our findings link the
group of skeletal ciliopathies to an additional IFT-B component, IFT172, similar to what has been shown for IFT-A.Cilia are hair-like structures that project from the surface of
most mammalian cells and are involved in diverse
signaling pathways. Mutations in genes encoding ciliary1DivisionofNephrology,DepartmentofMedicine,BostonChildren’sHospitaland
et de la RechercheMe´dicale U-983, Necker Hospital, 75015 Paris, France; 3Paris De
4Molecular Medicine Unit and Birth Defects Research Centre, University Colleg
Research Institute, TheUniversity ofQueenslandDiamantina Institute, Level 7, 37
Modeling, Duke University, Durham, NC 27710, USA; 7Department of System
Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Bos
MA02139, USA; 10Department ofMedicalGenetics, University of BritishColumb
The University of Queensland, Herston, QLD 4029, Australia; 12Bioinformatic P
13Genomic Platform, Imagine Institute, 75015 Paris, France; 14Department ofNep
France; 15Centre de Ne´phrologie et Transplantation Re´nale, Hoˆpital de la Conc
University, 1083 Budapest, Hungary; 17Genetic Services ofWestern Australia, Subi
sityofWesternAustralia,Crawley,WA6009,Australia; 19UQCentre forClinical Re
Medicine, The University of Sydney, Sydney, NSW 2006, Australia; 21Academic D
NSW2145,Australia; 22BirminghamChildren’sHospital, BirminghamB46NH,U
ham,Edgbaston, BirminghamB152TT,UK; 24DepartmentofMedicalGenetics, U
UK; 25Department ofMolecular Biology andBiochemistry, Simon FraserUniversit
Cancer Agency, Vancouver, BC V5Z 4S6, Canada; 27Medical Genetics Departm
28Division of Pediatric Genetics, Department of Pediatrics, CerrahpasaMedical Sc
Nephrology, National Institute of Child Health, Karachi 75510, Pakistan; 30Divis
33021, USA; 31Division of Human Genetics, The Children’s Hospital of Philadel
Hospital of Philadelphia, Philadelphia, PA 19104-4399, USA; 33Renal Medicine,
Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA; 35Departmen
36Department of Endocrinology, Royal Brisbane and Women’s Hospital, James
Hughes Medical Institute
38These authors contributed equally to this work
39These authors contributed equally to this work and are co-senior authors
*Correspondence: friedhelm.hildebrandt@childrens.harvard.edu (F.H.), sophie
http://dx.doi.org/10.1016/j.ajhg.2013.09.012. 2013 The Authors
This is an open-access article distributed under the terms of the Creative Comm
reproduction in any medium, provided the original author and source are cre
The Americanproteins lead to ‘‘ciliopathies,’’ a collection of complex
developmental disorders of multiple organ systems.1–3
Although there is broad clinical overlap, ciliopathiesHarvardMedicalSchool,Boston,MA02115,USA; 2InstitutNationalde laSante´
scartes University, Sorbonne Paris Cite´, Imagine Institute, 75015 Paris, France;
e London Institute of Child Health, London, WC1N 1EH, UK; 5Translational
Kent Street,Woolloongabba,QLD4102,Australia; 6Center forHumanDisease
s Biology, Harvard Medical School, Boston, MA 02115, USA; 8Division of
ton, MA 02215, USA; 9Harvard-MIT Health Sciences and Technology, Boston,
ia, Vancouver, BCV6H3N1,Canada; 11School of Paediatrics andChildHealth,
latform, Paris Descartes University, Sorbonne Paris Cite´, 75270 Paris, France;
hrology,NeckerHospital, AssistancePublique –Hoˆpitaux de Paris, 75015Paris,
eption, Marseille 13005, France; 161st Department of Pediatrics, Semmelweis
aco,WA 6008, Australia; 18School of Paediatrics andChildHealth, TheUniver-
search, TheUniversityofQueensland,Herston,QLD4029,Australia; 20Genetic
epartment ofMedical Genetics, The Children’s Hospital atWestmead, Sydney,
K; 23Centre forRareDiseases andPersonalisedMedicine,University ofBirming-
niversity ofCambridge,Cambridge Biomedical Campus,CambridgeCB2 0QQ,
y, Burnaby, BCV5A1S6,Canada; 26Genome Sciences Centre, BritishColumbia
ent, Istanbul Medical Faculty, Istanbul University, Istanbul 34093, Turkey;
hool, Istanbul University, Istanbul 34098, Turkey; 29Department of Paediatric
ion of Pediatric Nephrology, Joe DiMaggio Children’s Hospital, Hollywood, FL
phia, Philadelphia, PA 19104, USA; 32Division of Nephrology, The Children’s
Brigham and Women’s Hospital, Boston, MA 02215, USA; 34Department of
t of Pediatrics, University of Washington, Seattle, WA 98195-6320, USA;
Mayne Building, Butterfield Road, Herston, QLD 4029, Australia; 37Howard
.saunier@inserm.fr (S.S.)
ons Attribution License, which permits unrestricted use, distribution, and
dited.
Journal of Human Genetics 93, 915–925, November 7, 2013 915
have been divided into subgroups on the basis of their
predominant clinical phenotype and major organ involve-
ment; nephronophthisis-related ciliopathies (NPHP-RCs)
and skeletal ciliopathies are such examples. Whereas by
definition NPHP-RCs show cystic renal degeneration,2
skeletal ciliopathies primarily manifest with a bone-related
phenotype, such as polydactyly (e.g., in short-rib-polydac-
tyly syndromes [SRPSs; MIM 263510] and Ellis-van-Cre-
veld syndrome [EVC; MIM 225500]), thoracic dystrophy
(e.g., in SRPSs and asphyxiating thoracic dystrophy
[ATD], also known as Jeune syndrome [MIM 208500]),
phalangeal cone-shaped epiphysis (e.g., in Mainzer-
Saldino syndrome [MZSDS; MIM 266920]), or dolicho-
cephaly and hypodontia and/or microdontia (e.g., in
cranioectodermal dysplasia [CED], also known as Sense-
nbrenner syndrome [MIM 218330]).4 Whereas proteins
associated with NPHP-RCs mainly function at the
ciliary transition zone,5 most proteins associated with
skeletal ciliopathies have been shown to participate in
intraflagellar transport (IFT). IFT is an evolutionarily
conserved kinesin- and dynein-mediated bidirectional
trafficking system essential for cilium assembly and main-
tenance and is facilitated by two major subcomplexes, A
(IFT-A) and B (IFT-B). Ciliary proteins found to be defective
in skeletal disorders currently encompass the following
four main subgroups: (1) all six subunits of IFT-A6–11 and
its motor protein, DYNC2H1,12 whose defects have been
shown to disrupt retrograde transport and cause IFT
protein accumulation at the ciliary tip; (2) NEK1, a
serine-threonine kinase involved in cell-cycle control and
ciliogenesis;13 (3) EVC and EVC2, both located at the
basal body as positive regulators of sonic hedgehog
signaling;14,15 and (4) IFT80 (intraflagellar transport 80
homolog [Chlamydomonas]), one of 14 subunits of IFT-B,
which is involved in anterograde IFT. Although all six
IFT-A components are implicated in skeletal ciliopathies,
none of the IFT-B components have been shown to play
a role in human disease to date; the only exception is
IFT80, encoded by IFT80 (MIM 611263), the first gene
identified as causing ATD when mutated.16 Given the
fact that IFT-B is critical for ciliogenesis in mice,17,18 we
sought to elucidate whether additional IFT-B proteins are
defective in individuals with ciliopathies, particularly
skeletal ciliopathies.
To identify additional genes mutated in ciliopathies, we
applied targeted candidate-gene sequencing and whole-
exome capture with next-generation sequencing (also
known as whole-exome resequencing [WER]) to a large
multicenter cohort of 1,530 individuals with ciliopathies.
Written informed consent was obtained from all indi-
viduals enrolled in this study and approved by the institu-
tional review boards at the University of Michigan, the
University College London Institute of Child Health (in
partnership with the Great Ormond Street NHS Hospital
Trust), Paris Descartes University, University of British
Columbia, University of Queensland, University of
Birmingham, and Duke University Medical Center. The916 The American Journal of Human Genetics 93, 915–925, Novembdiagnosis of NPHP-RCs and/or ATD was based on pub-
lished clinical criteria.19 Mutation analysis was performed
by three different approaches in five independent cohorts
of individuals with NPHP-RCs or skeletal ciliopathies. In 12
families, we identified a total of 14 individuals who had
biallelic mutations in IFT172 (intraflagellar transport 172
homolog [Chlamydomonas], also known as SLB, selective
LIM binding factor homolog [RefSeq accession number
NM_015662.1, MIM 607386]) and who shared a pheno-
type including skeletal abnormalities, nephronophthisis
(NPHP), and liver and eye involvement, consistent with
the diagnosis of complex ATD or MZSDS (Table 1). When-
ever available, we obtained parental DNA to show segrega-
tion of a recessive trait by Sanger sequencing (Figure S1,
available online, and Table 1).
First, we performed a candidate-gene screening of all 14
genes encoding IFT-B complex proteins (Table S1) in 1,056
affected individuals with NPHP-RCs by applying a recently
developed mutation-analysis method of microfluidic
array-based multiplex PCR and consecutive barcoded
next-generation sequencing (NGS).20 As a result, we
detected seven individuals with recessive IFT172 muta-
tions in five families. Three individuals from two families
were homozygous for missense mutations (A3189-21,
c.886C>T [p.Arg296Trp]; A2052-21 and A2052-22,
c.4630C>T [p.Arg1544Cys]). Another four individuals
from three families were compound heterozygous for
a truncating and a missense mutation (A3215-21,
c.2716C>T [p.Gln906*] and c.4607T>C [p.Leu1536Pro];
F108-21, c.3228þ1G>A and c.4607T>C [p.Leu1536Pro];
A3037-21 and A3037-22, c.4925_4928delGAGA
[p.Arg1642Lysfs*32] and c.5179T>C [p.Cys1727Arg]). All
detected missense residues were highly conserved
throughout evolution (Table 1). Most affected individuals
exhibited NPHP with progressive renal insufficiency in
childhood and reached end-stage renal disease (ESRD) by
20 years of age. Three subjects (A3215-21, A2052-21, and
A2052-22) showed thoracic dystrophy with chronic respi-
ratory distress, necessitating intermittent mechanical
ventilation (Figure 1A). All three presented with the
clinical characteristics of ATD: thoracic dystrophy with
a trident acetabular roof and shortening of the long
bones (Figure 1 and Table 1). The affected siblings from
family A2052, as well as three other individuals (A3037-
21, A3037-22, and F108-21), displayed phalangeal cone-
shaped epiphysis, a hallmark of MZSDS (Figure 1G), in
addition to liver fibrosis and retinal dystrophy. Interest-
ingly, both siblings from family A2052 also exhibited cere-
bellar vermis hypoplasia, representing an exceedingly rare
co-occurrence of ATD, MZSDS, and Joubert syndrome
(JBTS [MIM 213300]).21 Three of the individuals with
MZSDS (A3037-21, A3037-22, and F108-21) also presented
with obesity and impaired glucose tolerance, suggesting
a phenotypic overlap with Bardet-Biedl syndrome (BBS
[MIM 209900]) (Table 1). Mutations in genes most
frequently associated with NPHP (NPHP1–NPHP13) had
been previously excluded in all affected individuals.22er 7, 2013
Table 1. IFT172 Mutations in 14 Individuals from 12 Families Affected by Skeletal Ciliopathies, ATD and MZSDS
Individuala
Ethnic
Origin
Nucleotide
Mutationb
Deduced Protein
Alteration
Exon or Intron
(Zygosity,
Segregation)
Amino Acid
Evolutionary
Conservation
PolyPhen-2
(HumVar)
Mutation
Taster
Parental
Consan-
guinity
Clinical
Diagnosis
Skeletal
Features
Renal
Disease
(ESRD)
Other Clinical
Features
NPH2218 Hungarian c.432delA p.Lys144Asnfs*15 6 (het, p) - - - no ATD, JBTS TD, SS,
SLB
NPHP (6 years) RD, LF, OMA, CVH, ID,
obesity
c.4161G>Ac p.Arg1387Serfs*7 38 (het, m) - - -
A3189-21 Pakistani c.886C>Td p.Arg296Trp 9 (hom) D. melanogaster 0.967 DC yes MZSDS SS NPHP (9 years) RD, ID, died at 12 years
UCL-87 Turkish c.1232T>A p.Ile411Asn 13 (hom)
(het, p/m)
D. melanogaster 0.890 DC yes ATD TD, TA,
PD (feet)
none () LF, died at 18 months
UCL-107 Turkish c.1232T>A p.Ile411Asn 13 (hom) D. melanogaster 0.890 DC yes ATD TD, TA none () LF, died at 3 months
NPH2161 French c.1390_1395del
GATATT
p.Asp464_Ile465
del
14 (het) D. melanogaster
and D. rerio
- - ND MZSDS BD NPHP (34 years) RD, cholestasis
c.5179T>Ce p.Cys1727Arg 48 (het) D. rerio 0.648 DC
B1 Belgian c.1671_1672dupAG p.Val558Glufs*12 16 (het, p) - - - no ATD TD, TA,
PSCE,
BD, PD
none () RD, ID
c.5179T>Ce p.Cys1727Arg 48 (het, m) D. rerio 0.648 DC
SKDP-44.3 British c.2158delC p.Arg720Valfs*28 21 (het, m) - - - no ATD TD, TA,
SS, BD
mild structural
abnormalities
RD, cholestasis, OMA,
ID, obesity
c.5179T>Ce p.Cys1727Arg 48 (het, p) D. rerio 0.648 DC
A3215-21 South
American
c.2716C>T p.Gln906* 25 (het, m) - - - no ATD TD, SS,
GV
NPHP
(12 years),
RTX (13 years)
ID
c.4607T>C p.Leu1536Pro 42 (het, p) C. reinhardtii 0.807 DC
F108-21 German c.3228þ1G>A 50 splice site 29 (het, m) - - - no MZSDS PCSE, BD NPHP (11 years) RD, LF, IGT, obesity
c.4607T>C p.Leu1536Pro 42 (het, p) C. reinhardtii 0.807 DC
SKDP-165.3 Singaporean
and
Malaysian
c.3907C>T p.Arg1303* 35 (het, p) - - - no ATD TD, TA,
PD, SLB
early cystic
dysplasia
LF, VSD,
hydrocephalus, died
by induced abortionc.4630C>T p.Arg1544Cys 42 (het, m) D. melanogaster 0.991 DC
A2052-21 and
A2052-22
Filipino c.4630C>T p.Arg1544Cys 42 (hom)
(het, p/m)
D. melanogaster 0.991 DC yes ATD, MZSDS,
JBTS
TD, TA,
PCSE, BD
NPHP (2 years),
RTX (4 years)
RD, LF, OMA, CVH, ID
A3037-21 and
A3037-22
European
American
c.4925_4928del
GAGA
p.Arg1642Lysfs*32 46 (het, p) - - - no MZSDS PCSE, BD NPHP (20 years) RD, LF, obesity
c.5179T>Ce p.Cys1727Arg 48 (het, m) D. rerio 0.648 DC
Abbreviations are as follows: BD, brachydactyly; ESRD, end-stage renal disease; CVH, cerebellar vermis hypoplasia; DC, predicted to be ‘‘disease causing’’; GV, genu valgum; het, heterozygous; hom, homozygous; ID, in-
tellectual disability; IGT, impaired glucose tolerance; ATD, asphyxiating thoracic dystrophy; JBTS, Joubert syndrome; LF, liver fibrosis; m, maternal; MZSDS, Mainzer-Saldino syndrome; ND, no data; NPHP, nephronophthisis;
OMA, ocular motor apraxia; p, paternal; PD, polydactyly; PCSE, phalangeal cone-shaped epiphysis; RD, retinal degeneration; RTX, renal transplantation; SLB, short long bone; SS, short stature; TA, trident acetabulum; TD,
thoracic dystrophy (small bell-shaped thorax); and VSD, ventriculoseptal defect.
aIn sibling cases, clinical information refers to the underlined individual.
bcDNA mutations are numbered according to human cDNA RefSeq NM_015662.1 (IFT172); þ1 corresponds to the A of the ATG start translation codon.
cThis variant abrogates the 30 splice site (Figure S2). It is in 1000 Genomes (its minor allele frequency is not annotated), but not in the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project Exome
Variant Server (EVS).
dNHLBI EVS (n ¼ 6,503 control subjects): T/T ¼ 0; T/C ¼ 1; C/C ¼ 6,502.
eNHLBI EVS (n ¼ 6,503 control subjects): C/C ¼ 0; C/T ¼ 1; T/T ¼ 6,502.
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Figure 1. Clinical Characteristics of Individuals with Recessive Mutations in IFT172
(A) A chest X-ray of individual A3215-21 shows a narrowed, bell-shaped thorax and short ribs. Note the tracheostomy for ventilation.
(B) A hip X-ray of individual UCL-87 demonstrates a trident acetabular roof with spurs (white arrowheads).
(C) Postaxial polydactyly of the feet in individual UCL-87.
(D) A chest X-ray of individual UCL-107 shows a narrowed, bell-shaped thorax.
(E) Obesity and short stature of individual NPH2218 at 10 years of age.
(F) Renal histology of individual NPH2218 exhibits dilated tubules, disruption of the tubular basement membrane, and extensive
interstitial fibrosis.
(G) A hand X-ray of individual A3037-21 shows brachydactyly with cone-shaped epiphysis of the middle phalanges.
(H) A babygram of individual SKDP-165.3 shows a turricephaly-like skull shape, absent nasal bone, postaxial tetramelic hexadactyly,
shortened and curved long bones, short ribs, mild platyspondyly, and spur-like projections of the acetabular roof.
(I) A trident acetabular roof with spurs (white arrowheads) in individual UCL-107.
(J) Cranial MRI depicts partial agenesis of the cerebellar vermis in individual NPH2218.
(K) Brachydactyly of individual NPH2218.
(L) Narrow thorax of individual UCL-107.Similarly, we conducted bidirectional Sanger sequencing
of the coding exons and intron-exon boundaries of all 14
IFT-B-encoding genes in another cohort of 296 individuals
with ciliopathies. We thereby identified compound-
heterozygous changes in IFT172: the previously identified
missense mutation c.5179T>C (p.Cys1727Arg) and
a frameshifting 2 bp deletion, c.1671_1672dupAG
(p.Val558Glufs*12), in a Belgian female with ATD (B1,
Table 1 and Figure S1). Notably, her initial symptoms
were bilateral postaxial polydactyly of the hands at birth
and night blindness at 5 years of age. Subsequent clinical
evaluation revealed a mildly hypoplastic left thoracic
cage, rhizomelic shortening of the limbs with brachydac-
tyly, short phalanges, and a trident acetabulum. Ultraso-918 The American Journal of Human Genetics 93, 915–925, Novembnography at the time of ascertainment revealed no signif-
icant abnormalities in the kidneys, liver, or pancreas.23
Second, by applying exon-enriched NGS of 1,209 ciliary
candidate genes, including those encoding all 14 IFT-B
components (‘‘ciliome sequencing’’),11 in another 115
individuals with NPHP-RCs, we found two individuals
with compound-heterozygous IFT172 mutations. Indivi-
dual NPH2218 carried two truncating mutations, a frame-
shift mutation in exon 6 (c.432delA [p.Lys144Asnfs*15]),
and a nucleotide change that affected the first base of
exon 38 and thus abrogated the acceptor splice site and
led to a truncated protein (c.4161G>A [p.Arg1387Serfs*7])
(Figure S2). This individual exhibited a severe phenotype
with shortened long bones, resulting in severe dwarfism,er 7, 2013
obesity, brachydactyly, and NPHP with early-onset ESRD
(Figures 1E, 1F, and 1K). Additionally, he also presented
with liver failure, retinal degeneration, severe intellectual
disability, oculomotor apraxia, and partial agenesis of the
cerebellar vermis, consistent with JBTS (Figure 1J). In
contrast, individual NPH2161 displayed a milder pheno-
type evoking MZSDS as a result of late-onset retinitis
pigmentosa, NPHP with adult-onset ESRD (at 34 years),
cholestasis, and short hands. This individual carried a
missense allele (c.5179T>C [p.Cys1727Arg], conserved to
D. rerio) and an in-frame deletion (c.1390_1395delGATATT
[p.Asp464_Ile465del], conserved to D. rerio and
D. melanogaster).
Third, WER was independently performed in two sepa-
rate ATD cohorts, one from the United Kingdom and one
from Australia. In the United Kingdom cohort, we per-
formed WER in 56 individuals with the clinical diagnosis
of ATD. We thereby identified a homozygous missense
mutation in IFT172 (c.1232T>A [p.Ile411Asn], conserved
to D. melanogaster) in an individual of consanguineous
Turkish descent (UCL-87). Parallel sequencing of 60 more
ATD cases with the use of a NGS gene-panel approach
revealed the same mutation in a second individual of
consanguineous Turkish descent (UCL-107). In addition
to showing characteristic ATD features, such as a bell-
shaped narrow thorax with short ribs, handlebar clavicles,
and a trident acetabulum (Figures 1B, 1D, 1I, and 1L),
both individuals displayed hepatosplenomegaly, dilated
intrahepatic bile ducts, and liver failure similarly to the
previously detected individuals (F108-21, A3037-21, and
A2052-21). In contrast to most of the described subjects,
UCL-87 additionally presented with postaxial polydactyly
of the feet (Figure 1C). Renal disease was not reported
in either of them. However, because both individuals
died within the first 18 months of life as a result of
respiratory (UCL-107)24 or liver (UCL-87) failure, renal
involvement could not be completely excluded or might
have developed later in life. WER variant analysis was per-
formed as previously described.25 In UCL-87, the above
mutation was one out of three remaining homozygous
missense variants found in three different genes. Only
two variants, the one in IFT172 and one in ERCC6, were
located on a long homozygosity stretch corresponding
to parental consanguinity.26 ERCC6 is known to cause
Cockayne syndrome type B (MIM 133540), a recessive
UV-sensitive nucleotide-excision-repair disorder character-
ized by neurological and sensory impairment, cachectic
dwarfism, and photosensitivity.27 Therefore, considering
the individual’s phenotype and taking the evolutionary
conservation of both missense variants into account,
IFT172 remained the most likely disease-associated candi-
date (Table S2).
In the Australian cohort, we performed WER in seven
individuals with ATD and identified two individuals with
compound-heterozygous mutations in IFT172 (SKDP-
165.3 and SKDP-44.3). SKDP-165.3 carried a truncating
mutation (c.3907C>T [p.Arg1303*]) and a missenseThe Americanmutation (c.4630C>T [p.Arg1544Cys], conserved to
D. melanogaster). SKDP-44.3 carried a single-base frame-
shift deletion (c.2158delC [p.Arg720Valfs*28]) and a mis-
sense mutation (c.5179T>C [p.Cys1727Arg], conserved
to D. rerio). Internal WER data of 993 unrelated control
individuals did not demonstrate any other person with
compound-heterozygous mutations in IFT172. An
ultrasound scan of SKDP-165.3 at 16 weeks of gestation
demonstrated a facial cleft with an absent nasal bone,
hydrocephalus, cardiac malformation, tetramelic poly-
dactyly, short long bones, and echogenic kidneys; the
pregnancy was terminated at this stage. Postmortem exam-
ination demonstrated intrauterine growth restriction, a
turricephaly-like skull shape, upper-lip paramedian cleft
extending into the palate, hypoplasia of the nasal bridge
and nose, postaxial hexadactyly of all four limbs, hydro-
cephalus, possible brain heterotopia, a ventriculoseptal
defect, bilateral adrenal hypoplasia, prominent hepatic
ductal plates, and early renal cystic dysplasia (Table 1).
Other skeletal changes included shortened and curved
long bones, relatively short ribs, mild platyspondyly, and
spur-like projections of the acetabular roof (Figure 1H).
ATD was considered the most likely diagnosis. WER was
performed as previously described.25 Given parental non-
consanguinity, compound heterozygosity was thought
the most likely form of inheritance. Seven genes carried
two or more novel (absent from public databases) or rare
(minor allele frequency < 0.001) nonsynonymous SNPs,
small insertions, or exon or splice-site deletions predicted
to be damaging.
Two of these genes (IFT172 and STXBP5L) were repre-
sented in the cilia proteome and had appropriate familial
segregation of variants; however, only IFT172 had two
variants that were in highly conserved regions and had a
deleterious effect predicted by PolyPhen-2, SIFT, and
MutationTaster. Thus, IFT172 was considered the most
likely candidate (Tables S3 and S4).
SKDP-44.3, the last individual of the Australian cohort,
had neonatal respiratory distress. Poor vision was noted
from the age of 6 weeks, leading to the diagnosis of retinal
dystrophy. Speech was delayed, and brain MRI revealed
mild ventriculomegaly. Frequent and severe chest infec-
tions led to a skeletal survey, which showed narrowing of
the thorax and resulted in a diagnosis of ATD. This indivi-
dual was also noted to have mild renal structural
abnormalities, obesity, marked rhizomelic shortening,
and brachydactyly. WER data for SKDP-44.3 was similarly
filtered; after Sanger sequencing for appropriate segrega-
tion within the family, only IFT172 remained as a possible
candidate gene (Tables S3 and S4).
IFT172 encodes IFT172, a 1,749-residue protein (the
largest of all known IFT proteins) containing 9 N-terminal
WD-40, 1 LIM, and 14 C-terminal TPR (tetratricopeptide
repeat) domains. The detected mutations lead to protein
changes in both principal domain structures and have a
slight predominance toward the C-terminal end, which
neighbors the loci of two extensively studied animalJournal of Human Genetics 93, 915–925, November 7, 2013 919
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Figure 2. Biallelic IFT172 Mutations, Deduced Impact at Protein Level, and Subcellular Localization of WT IFT172
(A) Exon structure of human IFT172 cDNA. The positions of the start codon (ATG) and stop codon (TGA) are indicated.
(B) Domain structure of IFT172, which contains 9 WD-40 repeats (WD), located N-terminal to 14 tetratricopeptide repeats (TPR) and 1
LIM domain. For the mutations detected, black arrows indicate positions in relation to exons and protein domains. Family numbers are
underlined. Abbreviations are as follows: H, homozygous; and h, heterozygous. IFT172 animal mutantswim (mouse, p.Leu1564Pro) and
fla11 (C. reinhardtii, p.Leu1615Pro) are indicated by red arrows. Note the proximity of the detected missense changes p.Leu1536Pro and
p.Arg1544Cys to the wim locus at position Leu1564.
(C) A partial protein alignment of IFT172 shows evolutionary conservation of the identified missense changes (p.Arg296Trp,
p.Ile411Asn, p.Leu1536Pro, p.Arg1544Cys, and p.Cys1727Arg).
(D) Antibody staining (polyclonal rabbit antibody, Abcam, 1:100) of WT IFT172 in human control fibroblasts shows axonemal and peri-
centriolar localization in comparison to acetylated tubulin (anti-acetylated alpha tubulin, mousemonoclonal antibody, Abcam, 1:1000).
(E and F) Localization of humanWT IFT172 constructs, once with anN-terminal GFP tag (E) and once with a C-terminal GFP tag (F), after
transfection of a 48 hr serum-starved NIH 3T3 cell line. Immunofluorescence on a confocal microscope (Zeiss, LSM 720) confirmed
axonemal localization with enrichment at the ciliary base upon overexpression.mutants, the wimple mouse (wim)17 and the thermosensi-
tive Chlamydomonas fla1128 (Figures 2A and 2B). Interest-
ingly, although both mutants represent missense changes
(p.Leu1564Pro for wim and p.Leu1615Pro for fla11), they
result in severe phenotypes and, in the case of wim, embry-
onic lethality.17
In accordance with previously reported human muta-
tions of genes encoding the IFT-A or IFT-B complex, most920 The American Journal of Human Genetics 93, 915–925, Novembaffected individuals carried one highly conserved missense
allele in transwith a functional null nonsense or frameshift
allele (Figures 2B and 2C). Accordingly, the observed phe-
notypes of the subjects in this study, especially the pheno-
type of SKDP-165.3, are reminiscent of the hypomorphic
avc1 mouse, which displays shortening of the long bones,
preaxial polydactyly, renal dysplasia, atrioventricular
septal defect, and hydrocephalus.29 Only NPH2218 carrieder 7, 2013
two truncating mutations, consequently associated with a
severe phenotype of multiple organ involvement, notably
malformations of the CNS. However, the homozygous
c.1232T>A (p.Ile411Asn) mutation of UCL-87 and UCL-
107 was also associated with a severe phenotype and early
death. This might be due to the substitution’s N-terminal
localization, given that the N terminus was recently shown
to be necessary for anterograde transport in Tetrahymena.30
However, health-care standards in the individuals’ respec-
tive countries have to be taken into account before a geno-
type-phenotype correlation can be considered. On the
other hand, SKDP-165.3 also demonstrated an extremely
severe phenotype; whether this would have been compat-
ible with postnatal life is unknown. This individual carried
one earlier truncatingmutation and the same C-terminally
located missense mutation as did family A2052. In conclu-
sion, even missense mutations can result in a severe
phenotype if located within a specific domain structure
of crucial protein function, as already demonstrated for
wim (Figures 2A and 2B).17
To investigate the subcellular localization of the wild-
type (WT) protein, we first performed immunofluores-
cence in primary human skin fibroblasts of healthy
controls. WT IFT172 localized to the axoneme and around
the base of the cilium (Figure 2D). Similar to endogenous
IFT172, N-terminally and C-terminally tagged constructs
localized to the ciliary axoneme upon overexpression (Fig-
ures 2E and 2F).
To evaluate the impact of the identified human muta-
tions on ciliogenesis, ciliary morphology, and composi-
tion, we examined cultured human fibroblasts from
affected individuals A2052-21, NPH2161, and NPH2218
and compared them to those of healthy controls. No sig-
nificant difference in the number of ciliated cells was
observed between mutants and controls. Cilia from
mutant fibroblasts were not shortened but unexpectedly
appeared longer than those of the controls (Figure 3A).
Similarly, we found that cilia from the remaining kidney
tubules of individual NPH2218 also appeared longer
(Figure S3). We next assessed the ciliary composition in
the three human fibroblast cell lines (A2052-21,
NPH2161, and NPH2218) and observed a partial loss of
the IFT-A protein IFT140 along the cilium, accompanied
by an accumulation of IFT140 at the basal body
(Figure 3B). Interestingly, we also observed a significant
decrease in adenylyl cyclase III (ACIII) staining along the
axonemes of all three human fibroblast cell lines
(Figure 3C). Reduced ciliary ACIII can result in defective
cyclic AMP (cAMP) signaling and consequent reduction
of the activity of protein kinase A (PKA), a negative regu-
lator of mammalian Sonic hedgehog signaling. Indeed,
we observed an abnormal accumulation of the catalytic
subunits of PKA (PKAc) at the base of the cilium in affected
individuals’ fibroblasts that were treated with the adeny-
late cyclase activator forskolin (Figure S4), suggesting
altered cAMP-PKA signaling. Together, these results indi-
cate that fibroblasts from affected individuals exhibit anThe Americanaltered ciliary composition and potentially lead to defects
in ciliary trafficking and cilia-mediated signaling.
To recapitulate the human phenotype and investigate
defective IFT172 in vivo, we performed zebrafish knock-
downwith twomorpholino oligonucleotides (MOs) target-
ing the exon 1-intron 1 and intron 1-exon 2 splice sites.
Both MOs led to a similar phenotype comparable to that
of the previously described ift172 zebrafish mutants,31,32
displayingventral body-axis curvature, formationof kidney
cysts, otolithdefects, andhydrocephalus (Figure 4BandFig-
ures S5C and S5E). In addition, morphants exhibited carti-
lage defects, demonstrated by Alcian-blue staining of the
craniofacial skeleton (Figure4B). Furthermore, uponknock-
down of ift172 in a rhodopsin-GFP transgenic zebrafish
line, we were able to visualize the impact on retinal
rhodopsin expression. We thereby demonstrated that the
level of rhodopsin-GFP was lower in ift172 morphants
than in controls, suggesting retinal degeneration
(Figure S5A). Lastly, by scanning electron microscopy of
the olfactory placode, we observed ciliogenesis defects,
including shortened and truncated cilia, in ift172 mor-
phants compared to controls (Figure S5B). Ciliogenesis
defects with fewer and shorter cilia have been previously
described in ift172 mutant zebrafish embryos,33 as well as
in the ift172 mouse mutant wim.17 In contrast to these
observations, the fibroblasts from the three individuals
with IFT172mutationswerenormally ciliated. This discrep-
ancy might be due to the nature of the identified human
mutations, each carrying at least one hypomorphic allele
that might partially conserve IFT172 function and thus
result in an overall milder phenotype.
IFT80, a 777 amino acid protein, shows striking similar-
ities to IFT172. Both proteins are part of the peripheral,
non-core, IFT-B complex, feature multiple N-terminal
WD-40 domains, and are implicated in individuals with
ATD when defective.16 Therefore, we investigated whether
IFT172 and IFT80 interact genetically with each other.
When comparing the phenotypes of both zebrafish mor-
phants, we observed striking similarities with regard to
body-axis curvature, formation of kidney cysts, and
pattern of cartilage defects (Figures 4B–4F). Moreover, the
combined injection of subphenotypic doses of both ift80
(1.5 ng) and ift172 (1.5 ng) MOs resulted in the same
phenotype as did injection of a full dose (3 ng) of each
MO alone, indicating genetic interaction (Figures 4B–4F
and Figures S5C and S5G).
In summary, we have identified mutations in IFT172 as
an additional cause of ATD and MZSDS in humans. In
contrast to ‘‘classical’’ ATD, which is due to mutated
IFT80 and DYNC2H1 and which typically manifests
without any extraskeletal symptoms,16,34 ATD in these
subjects with mutations in IFT172 is characterized by a
complex phenotype and is frequently associated with ex-
traskeletal involvement, notably NPHP, liver fibrosis,
retinal degeneration, obesity, and rarely, cerebellar vermis
hypoplasia (in A2052-21, A2052-22, and NPH2218).
None of the previously identified genes associated withJournal of Human Genetics 93, 915–925, November 7, 2013 921
Figure 3. Alteration of Ciliogenesis and Ciliary Composition in Human Mutant Fibroblasts
Control andmutant fibroblasts from individuals NPH2161, A2052-21, and NPH2218were starved for 48 hr for inducing ciliogenesis and
were fixed with MetOH.
(A) Staining of ARL13B (polyclonal rabbit antibody, Proteintech; 1:400), quantification of ciliated cells, and measurement of cilia length
with the use of Lucia G on Nikon DXM 1200 Software. Compared to controls, mutant fibroblasts displayed elongated cilia. The scale bar
represents 10 mm.
(B) Staining of acetylated-tubulin (mouse monoclonal antibody, Sigma Aldrich; 1:10,000), g-tubulin (goat polyclonal antibody, Santa
Cruz; 1:200), and IFT140 (polyclonal rabbit antibody, Proteintech; 1:100) showed a decrease in ciliary and an increase in basal body
IFT140 staining intensity in mutant fibroblasts compared to controls.
(C) Staining of adenylyl cyclase III (ACIII, rabbit polyclonal antibody, Santa Cruz; 1:100) showed a decrease in ciliary ACIII-staining in-
tensity in mutant fibroblasts compared to controls.
Images in (B) and (C) were recordedwith a Leica SP8 confocalmicroscope and analyzedwith ImageJ. All graphs show themean5 SEMof
at least three independent experiments. ‘‘ns’’ stands for not significant. *p< 0.05, **p< 0.01, and ***p< 0.001were calculated via Dunn’s
Multiple Comparison Test after the analysis of variance ANOVA test.
922 The American Journal of Human Genetics 93, 915–925, November 7, 2013
Figure 4. Knockdown of ift172 and ift80 and Genetic Epistasis between ift172 and ift80 in Zebrafish
(A–C) When compared to the control (A), both ift172 (B) and ift80 (C) morphants displayed similar ciliopathy phenotypes, including
ventral body-axis curvature (first row), formation of renal cysts (red arrows, second row), and cartilage defects with hypoplasia of the
Meckel’s cartilage (mc) and widening of ceratohyal angle (cha), as shown by Alcian-blue staining (third and fourth row).
(D–E) Zebrafish injected with subphenotypic doses of either ift172 (D) or ift80 (E) MO appeared no different than the control (A).
(F) Similar to a full dose of each MO alone, combined injection of subphenotypic doses of ift172MO and subphenotypic doses of ift80
MO resulted in body-axis curvature, formation of renal cysts, and cartilage defects.ATD or MZSDS have been implicated in CNS dysplasia, un-
derlying the special role of IFT172 in mammalian brain
development as demonstrated by another ift172-null
mouse model (slb).35 Because of the significant overlap
between the phenotypic features and other forms of
NPHP-RC, we introduce the alias ‘‘NPHP17’’ for IFT172.
The most similar phenotype, however, results from reces-
sive mutations in IFT140 (MIM 266920), encoding one of
six IFT-A subunits. Defective IFT140 is a frequent cause of
MZSDS and ATD with multiple extraskeletal involve-
ments, including NPHP, retinal degeneration, and liver
anomalies.11,36 Consistently, IFT172 is the only IFT-B pro-
tein shown to interact with IFT140 in a series of pull-down
experiments in mice.37 In that context, we have demon-
strated here that mutations in IFT172 lead to partial delo-
calization of IFT140 in fibroblasts of affected individuals,
suggesting the necessity of functional IFT172 for sufficient
IFT140 to enter the cilium. Taken together with the
Chlamydomonas and Tetrahymena data on the importance
of IFT172 for the transition from anterograde to retrograde
transport and for the turnaround at the flagellar tip,28,30
our data strengthen the hypothesis that IFT172 is indeed
involved in an interaction between the two subcomplexes,
IFT-A and IFT-B. By characterization of IFT172 as an addi-
tional gene associated with ATD and as the second gene
identified to be associated with MZSDS in humans,11,36
we link a subset of peripheral IFT-B proteins, consisting
of IFT172 and IFT80, to a phenotype that was also
described in individuals with mutations in genes encoding
IFT-A proteins. We hereby provide a further piece to the
puzzle of correlating protein complexes to certain clinical
phenotypes.The AmericanThe BBSome was the first protein complex whose
members were defined as defective in a distinct ciliopathy
phenotype, BBS.38 Similarly, the majority of NPHP- and
JBTS-related proteins were mapped to four distinct protein
modules located around the ciliary transition zone.39 IFT-A
has only recently been linked to a variety of human ciliopa-
thies that specifically involve skeletal dysplasia. We have
now shown that defects in the second IFT-B component,
IFT172, also result in a well-defined group of ciliopathies
with skeletal involvement. We therefore hypothesize
that complete or partial loss of function of other IFT-B
members might equally either lead to a bone-related
disorder or turn out to be embryonically lethal.Supplemental Data
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